MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/eurjpc/zwag043

Медицинская библиотека · European journal of preventive cardiology · 2026

Association between single-pill combination therapy use and blood pressure control in the Systolic Blood Pressure Reduction Intervention Trial: a post hoc analysis.

Rao Shreya, Segar Matthew W, Keshvani Neil, Soni Suha, Agarwal Anubha, Huffman Mark D, Hsue Priscilla, Vongpatanasin Wanpen, Ramachandran Vasan, Wang Thomas J, Pandey Ambarish

СтатьяРандомизированное исследованиеМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

AIMS: Blood pressure (BP) control remains suboptimal among US patients with hypertension. Single-pill combination (SPC) therapies are commonly used to improve adherence; however, their effectiveness for achieving early and sustained intensive BP control is unclear.

METHODS AND

RESULTS

We performed a post hoc analysis of Systolic Blood Pressure Intervention Trial (SPRINT) including 2736 participants propensity matched in a 1:2 ratio to compare effects of SPCs with equivalent multi-pill therapy. The estimated marginal odds of achieving target BP control were derived using generalized linear mixed models with repeated measures (LMMRMs). The association between time-updated SPC use and BP change in short- (≤6 months) and long-term (>6 months) follow-up was assessed with LMMRM and SPC * time interaction term. Multivariable Cox models evaluated the association of SPC use with cardiovascular events and serious adverse events (SAEs). Among SPRINT participants (n = 8623), 9.3% (n = 803) were prescribed SPC at baseline with greater use in the intensive vs. usual care group (5.79 vs. 3.90 per 100 person-months; P-diff < 0.001). Among matched pairs [SPC (n = 912); multi-pill therapy (n = 1824)], SPC use was associated with 22% increased likelihood of achieving target BP by 6 months [odds ratio (95% confidence interval), 1.22 (1.05, 1.42)]. Participants receiving SPCs (vs. multi-pills) experienced more rapid BP reduction in the first 6 months (-2.0 vs. -1.2 mmHg monthly change; P-diff < 0.001). Over long-term follow-up, participants using SPCs achieved significantly lower SBP at each time point. The risk of the primary CV composite endpoint and SAEs were not significantly different between groups.

CONCLUSION

Single-pill combination use resulted in greater likelihood of achieving target BP control and more rapid, sustained BP reduction without an increase in SAEs.

Для цитирования: Rao Shreya, Segar Matthew W, Keshvani Neil, Soni Suha, Agarwal Anubha, Huffman Mark D, Hsue Priscilla, Vongpatanasin Wanpen, Ramachandran Vasan, Wang Thomas J, Pandey Ambarish. Association between single-pill combination therapy use and blood pressure control in the Systolic Blood Pressure Reduction Intervention Trial: a post hoc analysis.. European journal of preventive cardiology. 2026. DOI: 10.1093/eurjpc/zwag043.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.